What is multiple sclerosis (MS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Multiple Sclerosis Definition

Multiple sclerosis is a chronic, inflammatory, autoimmune disease of the central nervous system that causes widespread focal degradation of the myelin sheath, variable axonal and neuronal injury, and progressive disability in young adults. 1

Core Pathophysiology

  • MS results from immune-mediated inflammation leading to demyelination with axonal transection throughout the central nervous system 2
  • The disease process involves loss of the myelin sheath surrounding nerve axons, accompanied by variable degrees of axonal damage and neuronal injury 1
  • Pathological features include inflammatory demyelination, axonal loss, gliosis, and the formation of characteristic sclerotic plaques in white and gray matter 3

Clinical Disease Subtypes

Relapsing-Remitting MS (RRMS):

  • Affects approximately 85% of patients at disease onset 1
  • Characterized by acute inflammatory relapses where nerve impulse conduction is disrupted, followed by remission phases with variable recovery 1
  • Represents the most common initial presentation with acute onset of neurological symptoms developing over hours to days 4
  • Over time, repeated relapses cause cumulative damage and scarring of myelin with progressive loss of neuronal function 1

Primary Progressive MS (PPMS):

  • Affects approximately 15% of clinical cases 1
  • Characterized by steadily increasing neurological disability from disease onset without distinct relapses or remissions 1, 4
  • Pathogenesis involves progressive neurological damage rather than the relapsing-remitting pattern 1

Secondary Progressive MS:

  • Develops when relapsing-remitting disease transitions to a phase of gradual disability accumulation affecting gait, coordination, and bladder function 5

Epidemiology and Demographics

  • MS typically presents in young adults with mean age of onset between 20-30 years 2, 5
  • Affects approximately 900,000 people in the United States 2
  • Worldwide prevalence ranges from 5 to 300 per 100,000 people, with higher rates at increased latitudes 2
  • Disproportionately affects women with a female-to-male ratio of nearly 3:1 2
  • Life expectancy is reduced compared to the general population (75.9 vs 83.4 years) 2

Etiology

  • The exact cause remains unknown, but research indicates a complex multifactorial etiology 1
  • Contributing factors include genetic predisposition, immunological dysfunction, and environmental triggers such as viral exposures 1, 2
  • Geography, vitamin D levels, hormones, and specific viral exposures all play documented roles in disease development 2, 5

Clinical Consequences

  • Weight loss, malnutrition, and cachexia are well-recognized features in MS patients 1
  • Common causes of nutritional decline include reduced mobility, fatigue, inappropriate diet, physical difficulty eating or drinking, poor appetite, visual impairment, cognitive decline, and dysphagia 1
  • The disease leads to physical disability, cognitive impairment, and substantially decreased quality of life 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The Properties of Cytokines in Multiple Sclerosis: Pros and Cons.

The American journal of the medical sciences, 2018

Guideline

Characteristic Presentations of Multiple Sclerosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.